PROTEIN KINASE C INHIBITORS
The present invention discloses compounds that are highly isozyme selective protein kinase C beta-1 and beta-2 isozyme inhibitors. Accordingly, the present invention provides a method of selectively inhibiting protein kinase C isozymes beta-1, and beta-2. As isozyme selective inhibitors of beta-1 an...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PAAL MICHAEL SCHOTTEN THEO MCDONALD JOHN HAMPTON III RUETHER GERD STENZEL WOLFGANG HEATH WILLIAM FRANCIS JR |
| description | The present invention discloses compounds that are highly isozyme selective protein kinase C beta-1 and beta-2 isozyme inhibitors. Accordingly, the present invention provides a method of selectively inhibiting protein kinase C isozymes beta-1, and beta-2. As isozyme selective inhibitors of beta-1 and beta-2, the compounds are therapeutically useful in treating conditions associated with diabetes mellitus and its complications, as well as other disease states associated with an elevation of the beta-1 and beta-2 isozyme. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI0817627TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI0817627TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI0817627TT13</originalsourceid><addsrcrecordid>eNrjZJAOCPIPcfX0U_D29HMMdlVwVvD08_B08gzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxwZ4GFobmZkbmISGGxsSoAQBa2SEA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROTEIN KINASE C INHIBITORS</title><source>esp@cenet</source><creator>PAAL MICHAEL ; SCHOTTEN THEO ; MCDONALD JOHN HAMPTON III ; RUETHER GERD ; STENZEL WOLFGANG ; HEATH WILLIAM FRANCIS JR</creator><creatorcontrib>PAAL MICHAEL ; SCHOTTEN THEO ; MCDONALD JOHN HAMPTON III ; RUETHER GERD ; STENZEL WOLFGANG ; HEATH WILLIAM FRANCIS JR</creatorcontrib><description>The present invention discloses compounds that are highly isozyme selective protein kinase C beta-1 and beta-2 isozyme inhibitors. Accordingly, the present invention provides a method of selectively inhibiting protein kinase C isozymes beta-1, and beta-2. As isozyme selective inhibitors of beta-1 and beta-2, the compounds are therapeutically useful in treating conditions associated with diabetes mellitus and its complications, as well as other disease states associated with an elevation of the beta-1 and beta-2 isozyme.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050831&DB=EPODOC&CC=SI&NR=0817627T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050831&DB=EPODOC&CC=SI&NR=0817627T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAAL MICHAEL</creatorcontrib><creatorcontrib>SCHOTTEN THEO</creatorcontrib><creatorcontrib>MCDONALD JOHN HAMPTON III</creatorcontrib><creatorcontrib>RUETHER GERD</creatorcontrib><creatorcontrib>STENZEL WOLFGANG</creatorcontrib><creatorcontrib>HEATH WILLIAM FRANCIS JR</creatorcontrib><title>PROTEIN KINASE C INHIBITORS</title><description>The present invention discloses compounds that are highly isozyme selective protein kinase C beta-1 and beta-2 isozyme inhibitors. Accordingly, the present invention provides a method of selectively inhibiting protein kinase C isozymes beta-1, and beta-2. As isozyme selective inhibitors of beta-1 and beta-2, the compounds are therapeutically useful in treating conditions associated with diabetes mellitus and its complications, as well as other disease states associated with an elevation of the beta-1 and beta-2 isozyme.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAOCPIPcfX0U_D29HMMdlVwVvD08_B08gzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxwZ4GFobmZkbmISGGxsSoAQBa2SEA</recordid><startdate>20050831</startdate><enddate>20050831</enddate><creator>PAAL MICHAEL</creator><creator>SCHOTTEN THEO</creator><creator>MCDONALD JOHN HAMPTON III</creator><creator>RUETHER GERD</creator><creator>STENZEL WOLFGANG</creator><creator>HEATH WILLIAM FRANCIS JR</creator><scope>EVB</scope></search><sort><creationdate>20050831</creationdate><title>PROTEIN KINASE C INHIBITORS</title><author>PAAL MICHAEL ; SCHOTTEN THEO ; MCDONALD JOHN HAMPTON III ; RUETHER GERD ; STENZEL WOLFGANG ; HEATH WILLIAM FRANCIS JR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI0817627TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>PAAL MICHAEL</creatorcontrib><creatorcontrib>SCHOTTEN THEO</creatorcontrib><creatorcontrib>MCDONALD JOHN HAMPTON III</creatorcontrib><creatorcontrib>RUETHER GERD</creatorcontrib><creatorcontrib>STENZEL WOLFGANG</creatorcontrib><creatorcontrib>HEATH WILLIAM FRANCIS JR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAAL MICHAEL</au><au>SCHOTTEN THEO</au><au>MCDONALD JOHN HAMPTON III</au><au>RUETHER GERD</au><au>STENZEL WOLFGANG</au><au>HEATH WILLIAM FRANCIS JR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROTEIN KINASE C INHIBITORS</title><date>2005-08-31</date><risdate>2005</risdate><abstract>The present invention discloses compounds that are highly isozyme selective protein kinase C beta-1 and beta-2 isozyme inhibitors. Accordingly, the present invention provides a method of selectively inhibiting protein kinase C isozymes beta-1, and beta-2. As isozyme selective inhibitors of beta-1 and beta-2, the compounds are therapeutically useful in treating conditions associated with diabetes mellitus and its complications, as well as other disease states associated with an elevation of the beta-1 and beta-2 isozyme.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_SI0817627TT1 |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | PROTEIN KINASE C INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T03%3A20%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAAL%20MICHAEL&rft.date=2005-08-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI0817627TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |